283 related articles for article (PubMed ID: 22841161)
21. Contribution of STAT1 to innate and adaptive immunity during type I interferon-mediated lethal virus infection.
Jung SR; Ashhurst TM; West PK; Viengkhou B; King NJC; Campbell IL; Hofer MJ
PLoS Pathog; 2020 Apr; 16(4):e1008525. PubMed ID: 32310998
[TBL] [Abstract][Full Text] [Related]
22. A role for the chemokine RANTES in regulating CD8 T cell responses during chronic viral infection.
Crawford A; Angelosanto JM; Nadwodny KL; Blackburn SD; Wherry EJ
PLoS Pathog; 2011 Jul; 7(7):e1002098. PubMed ID: 21814510
[TBL] [Abstract][Full Text] [Related]
23. Cyclophilin D Regulates Antiviral CD8
Condotta SA; Downey J; Pardy RD; Valbon SF; Tarrab E; Lamarre A; Divangahi M; Richer MJ
Immunohorizons; 2020 Apr; 4(4):217-230. PubMed ID: 32332052
[TBL] [Abstract][Full Text] [Related]
24. Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection.
Cousens LP; Peterson R; Hsu S; Dorner A; Altman JD; Ahmed R; Biron CA
J Exp Med; 1999 Apr; 189(8):1315-28. PubMed ID: 10209048
[TBL] [Abstract][Full Text] [Related]
25. CD70 deficiency impairs effector CD8 T cell generation and viral clearance but is dispensable for the recall response to lymphocytic choriomeningitis virus.
Munitic I; Kuka M; Allam A; Scoville JP; Ashwell JD
J Immunol; 2013 Feb; 190(3):1169-79. PubMed ID: 23269247
[TBL] [Abstract][Full Text] [Related]
26. Immunotherapeutic Blockade of CD47 Inhibitory Signaling Enhances Innate and Adaptive Immune Responses to Viral Infection.
Cham LB; Torrez Dulgeroff LB; Tal MC; Adomati T; Li F; Bhat H; Huang A; Lang PA; Moreno ME; Rivera JM; Galkina SA; Kosikova G; Stoddart CA; McCune JM; Myers LM; Weissman IL; Lang KS; Hasenkrug KJ
Cell Rep; 2020 Apr; 31(2):107494. PubMed ID: 32294445
[TBL] [Abstract][Full Text] [Related]
27. Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection.
Zhou S; Ou R; Huang L; Moskophidis D
J Virol; 2002 Jan; 76(2):829-40. PubMed ID: 11752172
[TBL] [Abstract][Full Text] [Related]
28. STAT5 is critical to maintain effector CD8+ T cell responses.
Tripathi P; Kurtulus S; Wojciechowski S; Sholl A; Hoebe K; Morris SC; Finkelman FD; Grimes HL; Hildeman DA
J Immunol; 2010 Aug; 185(4):2116-24. PubMed ID: 20644163
[TBL] [Abstract][Full Text] [Related]
29. Reduction of antiviral CD8 lymphocytes in vivo with dendritic cells expressing Fas ligand-increased survival of viral (lymphocytic choriomeningitis virus) central nervous system infection.
Wolfe T; Asseman C; Hughes A; Matsue H; Takashima A; von Herrath MG
J Immunol; 2002 Nov; 169(9):4867-72. PubMed ID: 12391197
[TBL] [Abstract][Full Text] [Related]
30. Toll-like receptor 3 has a protective role against West Nile virus infection.
Daffis S; Samuel MA; Suthar MS; Gale M; Diamond MS
J Virol; 2008 Nov; 82(21):10349-58. PubMed ID: 18715906
[TBL] [Abstract][Full Text] [Related]
31. The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis.
Gorman MJ; Poddar S; Farzan M; Diamond MS
J Virol; 2016 Sep; 90(18):8212-25. PubMed ID: 27384652
[TBL] [Abstract][Full Text] [Related]
32. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
[TBL] [Abstract][Full Text] [Related]
33. CD8+ T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons.
Shrestha B; Pinto AK; Green S; Bosch I; Diamond MS
J Virol; 2012 Sep; 86(17):8937-48. PubMed ID: 22740407
[TBL] [Abstract][Full Text] [Related]
34. MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection.
Zhou S; Kurt-Jones EA; Mandell L; Cerny A; Chan M; Golenbock DT; Finberg RW
Eur J Immunol; 2005 Mar; 35(3):822-30. PubMed ID: 15724245
[TBL] [Abstract][Full Text] [Related]
35. 2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo.
Szretter KJ; Daniels BP; Cho H; Gainey MD; Yokoyama WM; Gale M; Virgin HW; Klein RS; Sen GC; Diamond MS
PLoS Pathog; 2012; 8(5):e1002698. PubMed ID: 22589727
[TBL] [Abstract][Full Text] [Related]
36. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2.
Saito T; Hirai R; Loo YM; Owen D; Johnson CL; Sinha SC; Akira S; Fujita T; Gale M
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):582-7. PubMed ID: 17190814
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system.
Shrestha B; Zhang B; Purtha WE; Klein RS; Diamond MS
J Virol; 2008 Sep; 82(18):8956-64. PubMed ID: 18632856
[TBL] [Abstract][Full Text] [Related]
38. Gamma delta T cells facilitate adaptive immunity against West Nile virus infection in mice.
Wang T; Gao Y; Scully E; Davis CT; Anderson JF; Welte T; Ledizet M; Koski R; Madri JA; Barrett A; Yin Z; Craft J; Fikrig E
J Immunol; 2006 Aug; 177(3):1825-32. PubMed ID: 16849493
[TBL] [Abstract][Full Text] [Related]
39. Nonencapsidated 5' Copy-Back Defective Interfering Genomes Produced by Recombinant Measles Viruses Are Recognized by RIG-I and LGP2 but Not MDA5.
Mura M; Combredet C; Najburg V; Sanchez David RY; Tangy F; Komarova AV
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768856
[TBL] [Abstract][Full Text] [Related]
40. Anti-GITR agonist therapy intrinsically enhances CD8 T cell responses to chronic lymphocytic choriomeningitis virus (LCMV), thereby circumventing LCMV-induced downregulation of costimulatory GITR ligand on APC.
Clouthier DL; Zhou AC; Watts TH
J Immunol; 2014 Nov; 193(10):5033-43. PubMed ID: 25281716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
